TABLE 4.

Cost-effectiveness Analysis Results Summary

Perspective	Strategy	Mean Cost, CAD$	Incremental Cost (95% CI), CAD$	Mean Effectiveness, Wk in Steroid-Free Remission	Incremental Effectiveness (95% CI)	Incremental Cost-effectiveness Ratio (ICER)
Public health care payer	Standard care (step-up)	96,516	31,112 (2939–91,715)	83.07	11.29 (10.60–11.59)
	Early anti-TNF-α intervention	127,628		94.36		2756
Societal	Standard care (step-up)	100,956	33,508 (5436–94,308)	83.07	11.29 (10.60–11.59)
	Early anti-TNF-α intervention	134,464		94.36		2968

Probabilistic analysis of a 2-dimensional microsimulation model with 50 samples of 10,000 microsimulations. Costs are presented in 2017 Canadian dollars.